RxDoctor Payments Data

Macy Dickson

Family · Granite Falls, NCNPI 1356016497

Payments from drug & device makers

$4,463in general payments, 2019–2025

Across 261 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$958
  • Pfizer$463
  • Novo Nordisk$414
  • GSK$356
  • AstraZeneca$332
  • Bayer$230
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$4,463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,463 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$25,309
Medicare patients
97
Services billed
463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$82,516
MounjaroTirzepatide54$55,075
EliquisApixaban78$54,945
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$39,150
TrulicityDulaglutide33$36,051
RybelsusSemaglutide15$24,663
MyrbetriqMirabegron13$16,314
Tresiba Flextouch U-100Insulin Degludec26$12,820
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr26$11,826
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,409
LinzessLinaclotide15$9,193
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$8,385
Breo ElliptaFluticasone/Vilanterol16$6,402
Bevespi AerosphereGlycopyrrolate/Formoterol Fum13$5,280
VascepaIcosapent Ethyl12$4,785

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$414$107,17985 claims
Lilly USA, LLCMounjaro, Trulicity$151$91,12587 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$356$57,37897 claims
PfizerEliquis$463$54,94578 claims
AstraZenecaBreztri Aerosphere, Bevespi Aerosphere$332$16,68932 claims
AbbVieLinzess, Synthroid, Creon$958$15,42554 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.

Other family in Granite Falls

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →